|
Johnson JE.
"Alpha-gal Syndrome." Ferri’s Clinical Advisor 2027, edited by Ferri, F, 2027.
|
|
Bloch EM, Jacobs JW, Vannier E, Wormser GP, Gelfand JA, Sikand VK, Heller HM, Sood SK, Kirkman L, Johnson JE, Marcos LA, Lemieux JE, Smith RP, Woolley AE, Perry WA, Polgreen PM, Beekmann SE, Sullivan DJ, Auwaerter PG, Krause PJ.
"Guidance on the management of asymptomatic blood donors who test positive for Babesia." Clinical Infectious Diseases, 2025.
|
|
Johnson JE, Brotherton AL, Rossi MR, Sanchez MC, Beckwith CG.
"Long-Acting Injectable Antiretroviral Therapy for Treatment of Human Immunodeficiency Virus: A Review." Current HIV/AIDS Reports, vol. 22, no. 1, 2025, pp. 31.
|
|
Aldras Y, Johnson JE.
"Long COVID." Ferri’s Clinical Advisor 2024, edited by Ferri, F, 2024.
|
|
Dunkle, Lisa M., Kotloff, Karen L., Gay, Cynthia L., Áñez, Germán, Adelglass, Jeffrey M., Barrat Hernández, Alejandro Q., Harper, Wayne L., Duncanson, Daniel M., McArthur, Monica A., Florescu, Diana F., McClelland, R. Scott, Garcia-Fragoso, Veronica, Riesenberg, Robert A., Musante, David B., Fried, David L., Safirstein, Beth E., McKenzie, Mark, Jeanfreau, Robert J., Kingsley, Jeffrey K., Henderson, Jeffrey A., Lane, Dakotah C., Ruíz-Palacios, Guillermo M., Corey, Lawrence, Neuzil, Kathleen M., Coombs, Robert W., Greninger, Alex L., Hutter, Julia, Ake, Julie A., Smith, Katherine, Woo, Wayne, Cho, Iksung, Glenn, Gregory M., Dubovsky, Filip.
"Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico." New England Journal of Medicine, vol. 386, no. 6, 2022, pp. 531-543.
|
|
Mileno MD, Johnson JE.
"A Review of Current Vaccine Recommendations, Schedules for Children, Adults." Rhode Island medical journal (2013), vol. 103, no. 6, 2020, pp. 28.
|
|
Kalligeros M, Tashima KT, Mylona EK, Rybak N, Flanigan TP, Farmakiotis D, Beckwith CG, Sanchez M, Neill M, Johnson JE, Garland JM, Aung S, Byrd KM, O'Brien T, Pandita A, Aridi J, Macias Gil R, Larkin J, Shehadeh F, Mylonakis E.
"Remdesivir Use Compared to Supportive Care in Hospitalized Patients with Severe COVID-19: A Single-Center Experience." Open Forum Infectious Diseases, vol. 7, no. 10, 2020, pp. ofaa319.
|
|
Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R.
"SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States." Journal of the International AIDS Society, vol. 23, no. 7, 2020, pp. e25573.
|
|
Byrd K, Beckwith C, Garland J, Johnson J, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani F, Macias-Gil R, Mileno M, Ramratnam B, Rybak N, Sanchez M, Tashima K, Mylonakis E, Kantor R.
"SARS-CoV-2 and HIV Infection: a Rhode Island Perspective." 2020.
|
|
Johnson JE, Tunkel A.
"Bacterial Meningitis." Clinical Infectious Disease, edited by Schlossberg D & Cunha C, new york, new york, Oxford University Press, 2019.
|
|
Johnson JE, Mylonakis E.
"Listeria monocytogenes." Mandell, Douglas, and Bennett’s Principles and Practices of Infectious Diseases, edited by Bennet J, Dolin R, Blaser M, Philadelphia, Elsevier, 2019.
|
|
Patel KM, Johnson JE, Reece R, Mermel LA.
"Babesiosis-associated Splenic Rupture: Case Series From a Hyperendemic Region." Clinical Infectious Diseases, vol. 69, no. 7, 2018, pp. 1212-1217.
|
|
Patel, Kavin M., Johnson, Jennie, Zacharioudakis, Ioannis M., Boxerman, Jerrold L., Flanigan, Timothy P., Reece, Rebecca M.
"First confirmed case of Powassan neuroinvasive disease in Rhode Island." IDCases, vol. 12, 2018, pp. 84-87.
|
|
Patel KM, Johnson JE, Boxerman JL, Nau GJ.
"Group A streptococcus acute otitis media progressing to neuroinvasive disease in adults." IDCases, vol. 12, 2018, pp. 161-164.
|
